REVisiting Antibody structures and repertoires through advances in Mass spectrometry and Proteomics
REVAMP aims to develop innovative mass spectrometry techniques to comprehensively analyze the structural and functional diversity of human antibody repertoires, enhancing our understanding of immune responses.
Projectdetails
Introduction
In REVAMP, I will create innovative structural mass spectrometry (MS) and proteomics techniques to generate an unprecedented molecular understanding of the diversity and structural and functional characteristics of human antibody repertoires. These repertoires are highly personal and play a key role in our human immune response.
Research Focus
Recently, my research has taken a novel challenging avenue, with a focus on the development of cutting-edge MS-based techniques to better understand antibody structure and function. With these methods, I have started to monitor at the protein level changes in endogenous antibody repertoires with clonal resolution, including those induced by antigen-specific polyclonal responses in individuals.
Expansion of Techniques
Early studies were limited to IgG1, and in REVAMP, I aim to expand the toolbox to the full antibody repertoire, including all (sub)classes of antibodies. I aim to learn how and why antibody profiles in serum and other body fluids are alike or distinct, investigating:
- Structural differences
- Clonal differences
- Functional differences over time and between individuals
Targeting Sub-Repertoires
I will develop technologies to target the sub-repertoires recognizing antigens from pathogens. Following identification by advanced top-down and bottom-up de novo sequencing, these antibodies will be followed up functionally as potential therapeutic leads.
Special Attention to IgM
Special attention will be given to IgM, the largest human antibody, appearing first in the response to an antigen. We recently made the preliminary striking observation that its structure is ill-defined in textbooks, and that human IgM may be quite different from IgM in other mammals.
Methodological Advances
This project will benefit from our recent advances in structural analysis by:
- Single molecule mass spectrometry
- Mass photometry
- Atomic force microscopy
- Electron microscopy
Conclusion
REVAMP will overhaul our current view of the structural diversity of our human antibody repertoire and thereby elevate our understanding of how the human immune system functions.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.500.000 |
Totale projectbegroting | € 2.500.000 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 31-12-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- UNIVERSITEIT UTRECHTpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
In situ structural biology of human immune defenceDeveloping super-resolution cryo-correlative light and electron microscopy (SRcryoCLEM) to enhance in situ structural biology for antibody-mediated immunity and therapeutic advancements. | ERC Consolid... | € 1.976.553 | 2025 | Details |
Computational design of synthetic antibody repertoires for accelerated therapeutic discoveryCADABRE aims to design and optimize diverse human antibody repertoires with enhanced stability and developability for therapeutic discovery using advanced protein design and AI-driven screening methods. | ERC Advanced... | € 2.741.000 | 2024 | Details |
Learning the interaction rules of antibody-antigen bindingThis project aims to enhance antibody-antigen binding prediction by generating large-scale sequence and structural data through high-throughput screening and machine learning techniques. | ERC Consolid... | € 2.000.000 | 2024 | Details |
Dissecting the Functional Role of Mucosal IgA Clonal and Glycoprofiles for Effective Humoral Mucosal ProtectionThis project aims to characterize mucosal IgA proteoforms to enhance vaccine and monoclonal antibody development for improved respiratory immunity against viral threats. | ERC Starting... | € 1.486.245 | 2025 | Details |
Deciphering the antibody-microbiota axis in early lifeThis project aims to explore how early life immune exposures shape immunoglobulin repertoires and their impact on health, particularly allergies, by analyzing B cell receptor sequences and microbiota antigens. | ERC Starting... | € 1.650.000 | 2023 | Details |
In situ structural biology of human immune defence
Developing super-resolution cryo-correlative light and electron microscopy (SRcryoCLEM) to enhance in situ structural biology for antibody-mediated immunity and therapeutic advancements.
Computational design of synthetic antibody repertoires for accelerated therapeutic discovery
CADABRE aims to design and optimize diverse human antibody repertoires with enhanced stability and developability for therapeutic discovery using advanced protein design and AI-driven screening methods.
Learning the interaction rules of antibody-antigen binding
This project aims to enhance antibody-antigen binding prediction by generating large-scale sequence and structural data through high-throughput screening and machine learning techniques.
Dissecting the Functional Role of Mucosal IgA Clonal and Glycoprofiles for Effective Humoral Mucosal Protection
This project aims to characterize mucosal IgA proteoforms to enhance vaccine and monoclonal antibody development for improved respiratory immunity against viral threats.
Deciphering the antibody-microbiota axis in early life
This project aims to explore how early life immune exposures shape immunoglobulin repertoires and their impact on health, particularly allergies, by analyzing B cell receptor sequences and microbiota antigens.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
From A to BCR: B-Cell Receptor Repertoire Profiling for Antibody DevelopmentDit project ontwikkelt een geïntegreerde B-cel repertoire sequentiëringstechnologie om sneller en beter antilichamen te identificeren voor nieuwe geneesmiddelen en therapieën tegen kanker. | Mkb-innovati... | € 153.020 | 2020 | Details |
Human Antibody-enabled Cardiovascular Personalized TheranosisABCardionostics aims to develop a multi-marker PET/MRI system using human antibodies to personalize treatment and improve diagnosis of atherosclerosis in vulnerable patients. | EIC Pathfinder | € 3.639.665 | 2024 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
From A to BCR: B-Cell Receptor Repertoire Profiling for Antibody Development
Dit project ontwikkelt een geïntegreerde B-cel repertoire sequentiëringstechnologie om sneller en beter antilichamen te identificeren voor nieuwe geneesmiddelen en therapieën tegen kanker.
Human Antibody-enabled Cardiovascular Personalized Theranosis
ABCardionostics aims to develop a multi-marker PET/MRI system using human antibodies to personalize treatment and improve diagnosis of atherosclerosis in vulnerable patients.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.